Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Radiomics of Multiparametric MRI for Neoadjuvant Chemotherapy Outcomes Assessment in Breast Cancer

NCT03592004 is registered in ClinicalTrials.gov with Chinese Academy of Sciences as lead sponsor.

NCT NCT03592004
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03592004 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Radiomics of Multiparametric MRI for Neoadjuvant Chemotherapy Outcomes Assessment in Breast Cancer
Lead sponsor
Chinese Academy of Sciences
Phase
Observational
Overall status
Unknown status
Start date
July 18, 2018
Completion date
June 1, 2022
Enrollment
500 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer, multi-parametric mri, neoadjuvant chemotherapy, radiomics